Gout. Novel therapies for treatment of gout and hyperuricemia. - Wikidata - awgldk - TriplyDB

Gout. Novel therapies for treatment of gout and hyperuricemia.

Gout. Novel therapies for treatment of gout and hyperuricemia.

http://www.wikidata.org/entity/Q37350841

about

Functional and Structural Characterization of Purine Nucleoside Phosphorylase from Kluyveromyces lactis and Its Potential Applications in Reducing Purine Content in Food A broader view: microbial enzymes and their relevance in industries, medicine, and beyond.Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo.2011 recommendations for the diagnosis and management of gout and hyperuricemia.New and improved strategies for the treatment of gout Gout, genetics and ABC transporters.Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator.Allopurinol, benzbromarone, or a combination in treating patients with gout: analysis of a series of outpatients Genetics of hyperuricemia and gout: implications for the present and future.Current concepts in the treatment of gouty arthritis.Molecular basis of oxidative stress in gouty arthropathy.Investigational drugs for hyperuricemia.Xanthine oxidase inhibitory activity of the methanolic extracts of selected Jordanian medicinal plants.Optimization of novel and greener approach for the coproduction of uricase and alkaline protease in Bacillus licheniformis by Box-Behnken model.

P2860

Q28552877-0E5168E6-8099-4DEC-9C99-F45B5C503BCF Q30393023-BF0D6C19-472B-4D54-9D71-6BCCB3F12D4F Q34069534-7211AC00-D472-435C-B369-25E6B1DE51EA Q34250995-52281BCC-7F9E-4C75-AB6B-425E77A8D744 Q35026692-C38A7B3A-279B-4DF9-AEA5-67727E9BE9BD Q35508210-1D7EE638-EBF6-4132-B6CF-D7DD617E6508 Q36903272-1E99135B-890A-4BEB-AF6D-032F4E7DC7AC Q37639787-673E77C3-6CA9-4CD3-B5C1-C117847615A7 Q38073215-43939D7F-555C-46CB-B5DC-BE2B7412B0B4 Q38082745-98F4BF3F-F772-47E7-A43D-D49E047A60AA Q38411905-33A0FE3C-4D53-467D-9D67-FF742E9D92D2 Q38527441-F3A4F244-F6A0-420C-84C6-3099656FCE7E Q40497909-B4D1518F-D329-4C31-B7C3-2C41C0EB1808 Q47603107-02E2B6C1-DEBE-41CA-946F-21236DE485F2

P2860

Gout. Novel therapies for treatment of gout and hyperuricemia.

http://www.wikidata.org/entity/Q37350841

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Gout. Novel therapies for treatment of gout and hyperuricemia.

@en

Gout. Novel therapies for treatment of gout and hyperuricemia.

@nl

type

label

Gout. Novel therapies for treatment of gout and hyperuricemia.

@en

Gout. Novel therapies for treatment of gout and hyperuricemia.

@nl

prefLabel

Gout. Novel therapies for treatment of gout and hyperuricemia.

@en

Gout. Novel therapies for treatment of gout and hyperuricemia.

@nl

P1433

Q37350841-E4B6F67B-15FF-4FE2-8378-E326B3B8EB2D

P1476

Q37350841-05550E50-A6AB-4654-9A1A-F75489BE69CD

P2093

Q37350841-6FC923B5-5D93-4684-B2DF-1C7405B245AF

P2860

Q37350841-055AEC8C-01FA-4BB5-B218-3E65F85417E2

Q37350841-0CE695F2-F3EF-44C6-B65F-317292ADAA71

Q37350841-1BC10559-2B99-4DDE-810A-64D89650343E

Q37350841-1C9E7B4A-C7C3-40B6-B214-F2396BCDC26E

Q37350841-1E2A294F-880A-4C18-97DD-C647958E1133

Q37350841-22980364-B846-4111-9B2A-B97F0FFD1104

Q37350841-24168BD4-5401-48ED-BF35-C9E273BC6FC6

Q37350841-299FCACC-5C61-4DEB-A779-A85CD65211DF

Q37350841-381E2E8B-90A9-4310-9536-5906F47F24BB

Q37350841-38A74077-8A1B-4839-A8FB-2515F22B39B2

P2888

Q37350841-7FC95E98-9801-46B3-B915-918945E0F07D

P304

Q37350841-CDED55B1-A23C-44DA-A049-BF8809187F2E

P31

Q37350841-C1D3CA62-1FEC-4381-8AE5-4EB304223EE6

Q37350841-CB7B5229-B144-4EFB-9129-504D4AD2BFFF

P356

Q37350841-CCDDB24E-FA0C-4B90-9422-79150F4B20E1

P433

Q37350841-B171BE30-0298-45A0-A3FF-F5A6BD11B2B8

P478

Q37350841-52D46125-8316-457C-AA10-46EBCC9C7C79

P577

Q37350841-045F8087-C1CC-46F5-AB8C-6B53E24D4EA3

P5875

Q37350841-38A41E29-C159-4338-92F5-7202B164D272

P6179

Q37350841-8CADB60A-BFEB-459D-A01F-5CE1F003E877

P698

Q37350841-97FA5046-FC01-476F-BD1A-385AAAC13EFD

P921

Q37350841-6B8CBDE3-D1C8-4C5E-9428-4E4A6FB78729

Q37350841-6E7FB7BC-689A-4CFF-806C-32A70A262375

P932

Q37350841-B1455CCF-BD05-4E1B-8D43-8C05F86C9619

P356

P1433

Arthritis Research and Therapy

P1476

Gout. Novel therapies for treatment of gout and hyperuricemia.

@en

P2093

Robert Terkeltaub

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in the SLC2A9 gene cause hyperuricosuria and hyperuricemia in the dog

A pilot study of IL-1 inhibition by anakinra in acute gout

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout

An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition

SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

Gout-associated uric acid crystals activate the NALP3 inflammasome

P2888

P304

236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR2738

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26726067

http://www.w3.org/2001/XMLSchema#string

P6179

1038912101

http://www.w3.org/2001/XMLSchema#string

P698

19664185

http://www.w3.org/2001/XMLSchema#string

P921

P932

2745774

http://www.w3.org/2001/XMLSchema#string